Global pediatric vaccine market to hit $23B by 2015
The global pediatric vaccine market will likely hit a value of more than $23 billion by 2015, a market analysis shows.
From 2005 to 2011, pediatric vaccines doubled their market share, according to a Renub Research analysis, and will continue to shoot upward. Analysts can attribute much of that growth to blockbuster vaccines such as Pfizer's ($PFE) Prevnar 7 and Prevnar 13, Glaxo's Rotarix and Merck's ($MRK) Rotateq. Pediatric proprietary vaccines will probably lead the vaccine market with just less than 60% market share by 2015, the report says.
I know a popular sentiment is that vaccines are not that lucrative for Pharma compared to other drugs. That may be if you do side by side comparison, however 23 billion isn't chump change and the trend is such that the market continues to grow. If vaccines and pediatric vaccines in particular were not money makers for these companies they wouldn't make them.
If the people let government decide what foods they eat and what medicines they take, their bodies will soon be in as sorry a state as are the souls of those who live under tyranny." Thomas Jefferson.
Mother of two living in UK. Daughter (2007) born in USA, son (2010) born here. I'm pro natural birth, midwife care, breastfeeding, co-sleeping, baby wearing and a keen advocate of cloth diapering. I'm a full time working research scientist (physical sciences). Vaccines save lives.
Why don't you tell us about the motivations for Merck's lying about the efficacy of the mumps portion of the MMR, and their extensive efforts to cover that up?
|10 members and 11,048 guests|
|Alex0000 , bananabee , coconotcoco , IsaFrench , katelove , NaturallyKait , omarinbox1888 , sciencemum , Socks , valerievalira|
|Most users ever online was 449,755, 06-25-2014 at 12:21 PM.|